Clinical Trial Update: EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease [Phase 1]

View source ↗

Summary

Phase 1 trial of VEGF-D gene therapy delivered endocardially for severe coronary heart disease has completed, enrolling patients with angina pectoris and myocar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Heart Disease
• Myocardial Infarction

Drugs mentioned

• VEGF-D gene therapy (vascular endothelial growth factor D gene therapy)

Snippet

Sponsor: Kuopio University Hospital | Conditions: Angina Pectoris, Myocardial Infarction | Phase 1 | Status: COMPLETED